What Keimed does

Keimed Private Limited is the wholesale pharmaceutical distribution arm of Apollo Hospitals Enterprise Limited, one of India's largest listed healthcare groups. Headquartered in Hyderabad and operating with a workforce of 5,001-10,000 employees, Keimed supplies pharmaceuticals and medical supplies to pharmacies and hospitals, functioning primarily as the captive distribution channel supporting Apollo Hospitals' pharmacy operations and omnichannel pharma business across India. The company operates a domestic single-country wholesale distribution model, with no publicly disclosed standalone revenue, external customer base, technology stack, or pricing model. All available commercial signals tie Keimed's demand base to the Apollo Hospitals network.

The company is currently undergoing a major corporate restructuring as part of Apollo Hospitals' plan to spin off and list its digital health and pharmacy businesses. Under the composite scheme of arrangement, Apollo HealthCo (Apollo's digital health and pharmacy subsidiary) is to be demerged into a newly formed entity called Apollo Healthtech Limited, and Keimed is to be merged into the same entity. The National Company Law Tribunal (NCLT), Chennai bench approved this scheme on April 3, 2026, and has directed a shareholders' meeting for final approval on June 24, 2026. The National Stock Exchange issued a no-objection letter on December 23, 2025. Full completion is targeted for Q4 FY27, at which point Apollo Healthtech Limited will be listed on the NSE and BSE, with Apollo Hospitals retaining a 15% stake in the new entity.

Upon completion, the combined Apollo Healthtech entity will consolidate Keimed's wholesale distribution with Apollo HealthCo's digital health and pharmacy businesses, targeting Rs 25,000 crore (~$3.0B) in revenue by FY27. No AI/ML capabilities, proprietary technology platforms, patents, certifications, or external partnerships beyond the parent relationship are disclosed for Keimed in the source data. The strategic significance of Keimed within the combined entity, its revenue contribution, and its post-merger operating model will be a key determinant of investment outcomes once the restructuring is consummated.

Name

Keimed

Legal name

Keimed Private Limited

Website

https://keimed.com

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Keimed is Apollo Hospitals' wholly-owned wholesale pharmaceutical distribution subsidiary, supplying pharmaceuticals and medical supplies to pharmacies and hospitals across India, and is currently being merged into the new Apollo Healthtech Limited entity targeted for NSE/BSE listing by Q4 FY27.

Ownership category

akta.pro rank

Headquarters

HQ city

Hyderabad

HQ country

India

HQ region

Asia

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Personnel, Operations, Infrastructure

Distribution channels1 record

Core offering

Keimed is a wholesale pharmaceutical and medical supplies distributor that procures and supplies medicines and healthcare products to pharmacies and hospitals, primarily serving the captive needs of the Apollo Hospitals network. It functions as the backend pharma distribution arm of Apollo's omnichannel pharmacy and digital health business and is currently being merged into Apollo Healthtech Limited.

Product overview

Keimed is a wholesale pharmaceutical distributor that operates as part of Apollo Hospitals Enterprise's pharmacy and digital health business. The company is currently undergoing a restructuring process involving its merger into the newly formed Apollo Healthtech Limited entity.

Differentiator

Problem solved

Functional benefit

Products and services

• Wholesale Pharmaceutical and Medical Supplies Distribution Wholesale procurement and distribution of pharmaceuticals and medical supplies to hospital pharmacies and retail pharmacy outlets, primarily serving the Apollo Hospitals network and its omnichannel pharmacy and digital health business.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Apollo Hospitals Enterprise LimitedcoreStrategic or Co-development Partner · 3 April 2026Keimed Private Limited is being merged into Apollo Healthtech Limited, a new entity spun off from Apollo Hospitals Enterprise. This merger is part of a composite scheme of arrangement where Apollo HealthCo (digital health and pharmacy subsidiary) and Keimed (wholesale pharma distributor) are amalgamated into the new Apollo Healthtech entity. The restructuring involves the demerger of Apollo Hospitals' omnichannel pharma and digital health business into Apollo Healthtech Limited, with resultant listing planned on NSE and BSE by Q4FY27.

Recent moves6 records

Expansion highlights3 records

Direct peers

• Ascent Health & Wellness: Indian wholesale pharma distribution platform serving organized retail pharmacies and hospitals. Closest direct comparable to Keimed in scale, business model, and customer base within the Indian market.
• Medplus Health Services: Large Indian pharmacy retail chain with significant in-house wholesale and distribution operations. Comparable to Keimed as a vertically integrated pharma distribution and pharmacy platform serving Indian consumers.

Broad incumbents

• McKesson Corporation: Largest pharmaceutical distributor in North America, operating a global wholesale pharma distribution business. Comparable as a broad incumbent demonstrating the scale economics achievable in pharma distribution at maturity.
• Cencora (formerly AmerisourceBergen): Global pharmaceutical wholesale distributor and solutions provider. Comparable to Keimed as a broad incumbent in pharmaceutical distribution serving manufacturers, pharmacies, and health systems.
• Cardinal Health: US-headquartered global wholesale pharmaceutical distributor with extensive healthcare supply chain operations. Comparable as a broad incumbent illustrating the asset-heavy distribution model Keimed operates within.
• Sinopharm Group: China's largest pharmaceutical distributor and state-owned healthcare conglomerate with extensive distribution operations across Asia. Comparable as a regional incumbent in Asian pharma wholesale distribution.
• Phoenix Group: Leading European pharmaceutical wholesale distributor with pan-European pharmacy retail operations. Comparable as a broad incumbent showing the convergence of pharma distribution and pharmacy retail that the Apollo Healthtech model also targets.
• Medipal Holdings: Japan's largest pharmaceutical wholesaler operating distribution and healthcare businesses. Comparable as a broad incumbent in Asian pharmaceutical wholesale distribution with similar scale and integrated model.

Emerging players

• Tata 1mg (Tata Digital): Indian digital health and e-pharmacy platform backed by Tata Group. Partially comparable to the digital health/omni-pharmacy arm being combined with Keimed in Apollo Healthtech, representing the digitally native distribution model.
• PharmEasy (API Holdings): Indian online pharmacy and digital healthcare platform with integrated distribution. Comparable as an emerging player reshaping India's pharma distribution through digital channels, intersecting with Apollo Healthtech's omnichannel ambitions.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/keimed-limited

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Keimed